@article {Deurholt:2006::811,
title = "In Vitro Functionality of Human Fetal Liver Cells and Clonal Derivatives Under Proliferative Conditions",
journal = "",
parent_itemid = "",
publishercode ="",
year = "2006",
volume = "15",
number = "8-9",
publication date ="2006-08-01T00:00:00",
pages = "811-822",
itemtype = "ARTICLE",
url = "https://www.ingentaconnect.com/content/cog/ct/2006/00000015/f0020008/art00013",
doi = "doi:10.3727/000000006783464417",
keyword = "Liver function, Hepatocyte, Fetal, Proliferation, In vitro",
author = "Deurholt, Tanja and ten Bloemendaal, Lysbeth and Chhatta, Aniska A. and van Wijk, Albert C. W. A. and Weijer, Kees and Seppen, Jurgen and Oude Elferink, Ronald P. J. and Chamuleau, Robert A. F. M. and Hoekstra, Ruurdtje",
abstract = "Mature human hepatocytes are not suitable for large-scale in vitro applications that rely on hepatocyte function, due to their limited availability and insufficient proliferation capacity in vitro. In contrast, human fetal liver cells (HFLC) can be easily expanded in vitro. In this
study we evaluated the hepatic function of HFLCs under proliferative conditions, to determine whether HFLCs can replace mature hepatocytes for in vitro applications. HFLCs were isolated from fetal livers of 16 weeks gestation. Hepatic functions of HFLCs were determined in primary culture and
after expansion in vitro. Clonal derivatives were selected and tested for hepatic functionality. Results were compared to primary mature human hepatocytes in vitro. No differences were observed between primary HFLCs and mature human hepatocytes in albumin production and mRNA levels of various
liver-specific genes. Ureagenesis was 4.4-fold lower and ammonia elimination was absent in HFLCs. Expanding HFLCs decreased hepatic functions and increased cell stretching. In contrast, clonal derivatives had stable functionality and morphology and responded to differentiation stimuli. Although
their hepatic functions were higher than in passaged HFLCs, functionality was at least 20 times lower compared to mature human hepatocytes. HFLCs cannot replace mature human hepatocytes in in vitro applications requiring extensive in vitro expansion, because this is associated with decreased
hepatic functionality. Selecting functional subpopulations can, at least partly, prevent this. In addition, defining conditions that support hepatic differentiation is necessary to obtain HFLC cultures suitable for in vitro hepatic applications.",
}